1. Home
  2. CPF vs ENGN Comparison

CPF vs ENGN Comparison

Compare CPF & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Pacific Financial Corp New

CPF

Central Pacific Financial Corp New

HOLD

Current Price

$33.83

Market Cap

802.1M

Sector

Finance

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$7.21

Market Cap

647.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPF
ENGN
Founded
1954
1999
Country
United States
Canada
Employees
N/A
82
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
802.1M
647.1M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
CPF
ENGN
Price
$33.83
$7.21
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$37.00
$21.08
AVG Volume (30 Days)
109.1K
370.1K
Earning Date
04-29-2026
06-11-2026
Dividend Yield
3.39%
N/A
EPS Growth
45.18
N/A
EPS
0.78
N/A
Revenue
$51,817,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.62
N/A
P/E Ratio
$42.65
N/A
Revenue Growth
33.81
N/A
52 Week Low
$25.62
$2.66
52 Week High
$35.41
$12.25

Technical Indicators

Market Signals
Indicator
CPF
ENGN
Relative Strength Index (RSI) 52.71 43.67
Support Level $33.25 $6.15
Resistance Level $35.03 $7.33
Average True Range (ATR) 0.80 0.57
MACD -0.12 -0.06
Stochastic Oscillator 31.49 19.21

Price Performance

Historical Comparison
CPF
ENGN

About CPF Central Pacific Financial Corp New

Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services. It operates in single segment which is Banking operations.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: